Physician profile
Raymond Chang
NPI 1821654468
$2,094.58
in general payments reported to CMS, 2019-2025
8 companies · $355 in 2025
The $355 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.69 · 2023: $1,084 · 2024: $642 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280 · Education: $767 · Travel and Lodging: $33.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.08 |
| Education | $766.92 |
| Travel and Lodging | $33.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,076.20 | 2023-2024 | Omnia, Senza |
| Saluda Medical Americas, INC. | $340.29 | 2023-2025 | Evoke Scs, Evoke |
| Stryker Corporation | $192.31 | 2024 | Mild Device Kit |
| Avanos Medical | $181.70 | 2025 | On-Q Pump and Accessories |
| New World Medical,INC. | $147.43 | 2025 | Via360, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Spr Therapeutics, INC | $108.26 | 2024 | Sprint Pns System |
| Tersera Therapeutics LLC | $34.70 | 2024 | Prialt |
| Ultragenyx Pharmaceutical INC. | $13.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.